Efalizumab and aspartate aminotransferase increased 
Efalizumab and aspartate aminotransferase increased Patient Reports February 11, 2012
Efalizumab Side Effects Report #4831140-0
Efalizumab side effect was reported by a Physician from MEXICO on Oct 28, 2005. Male patient, 64 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, balance disorder, blood alkaline phosphatase increased, chills, dizziness
, haemoglobin decreased, headache , hypoacusis. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with ACETAMINOPHEN, AMOXICILLIN. Patient recovered.Efalizumab Side Effects Report #4844800-2
Efalizumab side effect was reported by a Physician from MEXICO on Nov 14, 2005. Male patient, 64 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, balance disorder, chills, dizziness
, haemoglobin decreased, headache , hypoacusis, red blood cell count decreased. Efalizumab dosage: 1 MG/KG, 1 WEEK, SUBCUTANEOUS. During the same period patient was treated with ACETAMINOPHEN, AMOXICILLIN. Patient recovered.Efalizumab Side Effects Report #4789261-7
Efalizumab side effect was reported by a Physician from UNITED STATES on Sept 20, 2005. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, chronic sinusitis, diarrhoea, epstein-barr virus test positive, headache
. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, WELLBUTRIN, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN, FLONASE. Patient was hospitalized and became disabled. Patient recovered.Efalizumab Side Effects Report #4832046-3
Efalizumab side effect was reported by a Physician from UNITED STATES on Nov 08, 2005. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, antibody test positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood immunoglobulin g increased, chills, diarrhoea, eosinophil count increased. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, WELLBUTRIN, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN, FLONASE. Patient was hospitalized and became disabled. Patient recovered.
Efalizumab Side Effects Report #4866351-1
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Dec 12, 2005. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood immunoglobulin g increased, eosinophil percentage increased, epstein-barr virus antigen positive, lipoma, sepsis
. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, WELLBUTRIN, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN, FLONASE. Patient was hospitalized and became disabled. Patient recovered.Efalizumab Side Effects Report #4875762-X
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Dec 20, 2005. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacteria urine identified, blood alkaline phosphatase increased, blood creatinine increased, bone marrow disorder, diarrhoea, epstein-barr virus antibody positive, escherichia infection. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, WELLBUTRIN, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN. Patient was hospitalized and became disabled. Patient recovered.
Efalizumab Side Effects Report #4882701-4
Efalizumab side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bacteriuria, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood creatinine increased, candidiasis, chills. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, WELLBUTRIN, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN, FLONASE. Patient was hospitalized and became disabled. Patient recovered.
Efalizumab Side Effects Report #4895651-4
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Jan 09, 2006. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, asymptomatic bacteriuria, blood alkaline phosphatase increased, candidiasis, culture urine positive, diarrhoea, enterococcal infection. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NEXIUM, VITAMIN E, CENTRUM SILVER, DOVONEX, BIAXIN, FLONASE. Patient was hospitalized and became disabled. Patient recovered.
Efalizumab Side Effects Report #5383037-8
Efalizumab side effect was reported by a Physician from SWITZERLAND on June 27, 2007. Female patient, 49 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, b-cell lymphoma, chronic lymphocytic leukaemia. Efalizumab dosage: unknown. Patient recovered.
Efalizumab Side Effects Report #4753508-3
Efalizumab side effect was reported by a Physician from AUSTRIA on Aug 15, 2005. Male patient, 40 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, fatigue, gamma-glutamyltransferase increased, hepatotoxicity, jaundice
, malaise. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with ETANERCEPT. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4596525-9
Efalizumab side effect was reported by a Health Professional from on Feb 14, 2005. Male patient, 31 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cough, cytomegalovirus infection
, dyspnoea, myalgia, pruritus. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient recovered.Efalizumab Side Effects Report #4650485-0
Efalizumab side effect was reported by a Health Professional from on Apr 25, 2005. Male patient, 31 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, cough, cytomegalovirus antibody positive, cytomegalovirus infection
, dyspnoea. Efalizumab dosage: 1MG/KG, 1/WEEK, SUBCUTANEOUS. Patient recovered.Efalizumab Side Effects Report #5079943-4
Efalizumab side effect was reported by a Health Professional from UNITED STATES on July 27, 2006. Female patient, 26 years of age, weighting 240.3 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, aspartate aminotransferase increased, asthenia, back pain
, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride increased, blood glucose increased, blood ph decreased. Efalizumab dosage: unknown. During the same period patient was treated with CLOBEX, COUMADIN, PROTOPIC OINTMENT, WELLBUTRIN, TOPICAL STEROIDS. Patient was hospitalized. Patient died on 06/30/2006.Efalizumab Side Effects Report #5121208-6
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Sept 18, 2006. Female patient, 26 years of age, weighting 240.3 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, aspartate aminotransferase increased, back pain
, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride increased, blood glucose increased, blood pressure increased, blood sodium decreased. Efalizumab dosage: 1.1 ML, 1/WEEK, SUBCUTANEOUS, SEE IMAGE. During the same period patient was treated with CLOBEX, COUMADIN, PROTOPIC OINTMENT, WELLBUTRIN, TOPICAL STEROIDS. Patient was hospitalized. Patient died on 06/30/2006.Efalizumab Side Effects Report #5141724-0
Efalizumab side effect was reported by a Physician from UNITED STATES on Oct 19, 2006. Female patient, 26 years of age, weighting 240.3 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: aggression, areflexia, arthralgia, aspartate aminotransferase increased, asthenia, back pain
, blood alkaline phosphatase increased, blood bilirubin increased, blood chloride increased. Efalizumab dosage: 1.1 ML, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CLOBEX, COUMADIN, PROTOPIC OINTMENT, WELLBUTRIN, TOPICAL STEROIDS. Patient was hospitalized. Patient died on 06/30/2006.